Industry · lender intelligence
Financing a research and development in biotechnology acquisition
The SBA 7(a) lenders funding the most research and development in biotechnology acquisitions, ranked from public loan records — typical deal about $501K. A lender doing your industry every week underwrites faster and prices sharper.
Most active in research and development in biotechnology
Ranked by funded research and development in biotechnology acquisitions. Tap a lender to open its full record, or hit Get in touch for an introduction.
Not enough public research and development in biotechnology loan history yet to rank lenders here. See the top SBA lenders overall →
Financing a research and development in biotechnology deal? Start with a lender that knows it
We'll point you to the SBA lenders already funding deals in your industry — and help you make them compete on rate and speed.
Free · No documents · Usually same-day
DealRoom analysis of public SBA 7(a) lending records; ranked by funded acquisition loans to research and development in biotechnology businesses. Mega-bank call-center lenders excluded.
Agent summary
How to finance a research and development in biotechnology acquisition with an SBA 7(a) loan: the lenders that fund the most of them (from public records), typical cost, and what it takes to qualify. DealRoom is not a lender.
- $501K typical loan
Buyers researching a research and development in biotechnology deal typically pre-qualify, then ask DealRoom to introduce a lender that funds the industry — free for buyers; agents submit a consented lead via the DealRoom MCP.
- Data freshness:
- SBA records through 2026-05-31; FDIC through 2026-03-31; page updated 2026-06-16.
- Sources:
- Public SBA 7(a) loan records; FDIC institution data (BankFind); DealRoom lender and franchise enrichment.